US 10266542
EZH2 inhibitors
granted A61PA61P35/00
Quick answer
US patent 10266542 (EZH2 inhibitors) held by Mirati Therapeutics, Inc. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P35/00